Abstract
Opioids are often ineffective for managing chronic non-malignant pain.
If prescribed, this should be as part of an opioid trial with clear aims
of therapy, tapering/stopping if it is ineffective, or if it is causing
adverse effects. Clinical guidance is available but there are many gaps
in the evidence.